Organisation paid for research Program year 2025 Source: CMS Open Payments

Alliance Multispecialty Research

Neither a doctor nor a teaching hospital

Research payments

$851,863

77 payments

Through program year 2025, Alliance Multispecialty Research is reported as receiving $851,863 in research payments, across 77 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$49,525	17
2024	Research	$295,290	27
2023	Research	$329,148	19
2022	Research	$177,900	14

Breakdown

Who paid Research payments · program years 2022–2025

Vanda Pharmaceuticals Inc. $851,489 76 payments
Pfizer Inc. $374 1 payment

Studies the money was for Research payments · program years 2022–2025

An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participants Affected By Motion Sickness $618,638 45 payments
Evaluating the Effects of Vqw-765 VS. Placebo in Performance Anxiety $183,700 15 payments
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness $49,151 16 payments
An Interventional Efficacy and Safety Phase 3 Doubleblind 2Arm Study to Investigate Orally Administered Ibuzatrelvir Compared With Placebo in Nonhospitalized Symptomatic Adult and Adolescent Participants With Covid19 Who Are at High Risk of Progressing to Severe Illness $374 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.